HSIC.NASDAQHenry Schein INC

DEF: Henry Schein Sets May 21, 2026 Annual Meeting, Announces CEO Transition

Sentiment:

Proxy Statement


Henry Schein, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for May 21, 2026, and detailed significant leadership changes including the appointment of Frederick M. Lowery as CEO.

Summary

  • Henry Schein, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on May 21, 2026.
  • The meeting will cover the election of ten directors, a say-on-pay vote for 2025 executive compensation, ratification of BDO USA, P.C. as auditors, and a shareholder proposal on majority voting.
  • Frederick M. Lowery has been appointed as the new Chief Executive Officer, effective March 2, 2026, succeeding Stanley M. Bergman, who will transition to Chairman Emeritus.
  • The Board of Directors size will be reduced from fifteen to ten members, effective at the end of the Annual Meeting.
  • The company engaged with stockholders on corporate governance, executive compensation, and capital allocation in 2025 and early 2026.
  • Executive compensation refinements for fiscal year 2025 included changes to the annual bonus program and long-term incentive program to focus more on financial performance.
  • KKR made a strategic investment of $250 million in May 2025, acquiring 3,285,152 shares at approximately $76.10 per share, and has increased its ownership limit to 19.9%.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to the clear CEO succession plan, strategic investment from KKR, and proactive engagement with stockholders on governance and compensation, indicating a well-managed transition and commitment to shareholder value.

Positives

  • Appointment of Frederick M. Lowery, an experienced healthcare executive, as the new CEO.
  • Stanley M. Bergman's continued role as Chairman of the Board, transitioning to Chairman Emeritus upon retirement as CEO.
  • Reduction in the size of the Board of Directors to ten members, with nine independent directors, enhancing governance efficiency.
  • Active engagement with stockholders on key corporate governance and compensation matters.
  • Refinements to executive compensation programs to increase focus on financial performance.
  • KKR's strategic investment of $250 million, strengthening the company's financial position.
  • The company's commitment to returning capital to stockholders through its stock repurchase program, with $780 million authorized and available as of December 27, 2025.

Negatives

  • The Compensation Committee adjusted the weighting of performance goals under the 2025 LTIP, shifting from 75% EPS and 25% ROIC to 50% EPS and 50% ROIC, which could alter incentive alignment.
  • PSUs granted in 2022 vested with a 0% payout due to not meeting EPS performance goals, indicating challenges in achieving prior performance targets.
  • PSUs granted in 2023 vested with a 21.5% payout, primarily due to not meeting EPS performance goals, suggesting ongoing performance pressures.
  • The company is reducing its Board size by five directors, indicating a streamlining of governance structure.

Risks

  • Potential for short-term stockholders to influence corporate governance decisions if supermajority voting standards are eliminated.
  • The company's reliance on financial metrics for executive compensation means that underperformance in EPS or ROIC could impact executive bonuses.
  • The increase in KKR's ownership limit to 19.9% could lead to increased influence by a single large shareholder.

Future Outlook

The company expresses confidence in its strategic direction, business model, and leadership team, positioning it for continued growth and value creation with Frederick M. Lowery at the helm.

Management Comments

  • Stanley M. Bergman: 'I look forward to discussing our plans for the Company's future at the Annual Meeting.'
  • Philip A. Laskawy: 'Throughout 2025, the Board maintained active and substantive engagement with management on all aspects of strategy and execution, including the value creation initiatives we launched during the year to increase efficiency, further enhance profitability and position us for long term growth.'
  • Philip A. Laskawy: 'On behalf of the entire Board of Directors, I want to thank Stan Bergman for his extraordinary leadership and invaluable contributions over more than four decades.'
  • Philip A. Laskawy: 'We are confident in Henry Schein's strategic direction, the strength of our business model, and the quality of our leadership team.'

Industry Context

StockSavvy.ai notes that Henry Schein's focus on healthcare distribution and manufacturing aligns with industry trends favoring integrated business models. The appointment of a new CEO with deep healthcare expertise is a common strategy for companies seeking to navigate evolving market dynamics and drive growth.

Comparison to Industry Standards

  • The company's peer group for compensation benchmarking includes major players in healthcare distribution and manufacturing such as Cardinal Health, Inc., Cencora, Inc., Owens & Minor, Inc., and McKesson Corporation.
  • Henry Schein's executive compensation strategy targets the median of the market, with a significant portion of pay at risk through performance-based incentives, which is a common practice in the industry.
  • The company's commitment to ESG matters, as highlighted by its Corporate Citizenship Barometer and Employee Resource Groups, reflects a growing trend among healthcare and distribution companies to prioritize social and environmental impact.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerStanley M. BergmanFrederick M. Lowery2026-03-02Retirement of Stanley M. Bergman as CEO
Chairman of the Board of DirectorsStanley M. BergmanTo be appointedFollowing the 2026 Annual MeetingStanley M. Bergman's retirement as Chairman
DirectorJoseph L. HerringN/AEnd of 2026 Annual MeetingNot standing for reelection
DirectorRobert J. HombachN/AEnd of 2026 Annual MeetingNot standing for reelection
DirectorScott SerotaN/AEnd of 2026 Annual MeetingNot standing for reelection
DirectorBradley T. ShearesN/AEnd of 2026 Annual MeetingNot standing for reelection

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board Size ReductionThe size of the Board of Directors will be reduced from fifteen to ten members.End of 2026 Annual MeetingStreamlines governance and potentially increases efficiency.
Leadership Structure ChangeThe roles of Chairman and CEO will no longer be combined, with a Lead Director in place.March 2, 2026Enhances board independence and oversight.
Director NominationKKR Designees Max Lin and William K. Dan Daniel were renominated for election at the Annual Meeting.2026-05-21Maintains KKR's representation on the board as per the strategic partnership.
Director Time Commitment PolicyThe Nominating and Governance Committee reviewed director commitments and affirmed compliance with the time commitment policy.March 2026Ensures directors can dedicate sufficient time to their duties.

Related Party Transactions

  • Strategic Partnership Agreement with KKR Hawaii Aggregator L.P., an affiliate of KKR, including a $250 million investment and board representation.
  • Consulting services provided by KKR Capstone Americas LLC, an affiliate of KKR, with fees of approximately $2.5 million incurred in fiscal 2025.
  • Employment of family members of former executives Brad Connett and James Breslawski in non-executive roles with compensation exceeding $120,000.

Stakeholder Impact

  • Shareholders will have the opportunity to vote on director elections, executive compensation, auditor ratification, and a majority vote proposal.
  • Employees (Team Schein Members) are highlighted for their importance, with ongoing efforts in culture, engagement, and career development.
  • Supplier partners are mentioned as key stakeholders in the company's 'Mosaic of Success'.

Next Steps

  • Stockholders to vote at the 2026 Annual Meeting of Stockholders on May 21, 2026.
  • Election of ten incumbent directors for terms expiring in 2027.
  • Consideration of the say-on-pay proposal for 2025 executive compensation.
  • Ratification of BDO USA, P.C. as the independent registered public accounting firm for fiscal year ending December 26, 2026.
  • Consideration of the shareholder proposal to Govern by Majority Vote.
  • Appointment of a new Chairman of the Board promptly following the Annual Meeting.

Key Dates

DateDescription
2026-05-212026 Annual Meeting of Stockholders
2026-03-02Frederick M. Lowery's effective date as Chief Executive Officer
2026-03-01Stanley M. Bergman's retirement as Chief Executive Officer
2026-01-10Board appointment of Frederick M. Lowery as CEO and Director
2025-11-04Amendment to Strategic Partnership Agreement with KKR increasing ownership limit
2025-05-16Issuance of 3,285,152 shares of common stock to KKR for $250 million
2025-04-08Date of Proxy Statement and Notice of Annual Meeting
2025-03-02Frederick M. Lowery's appointment as CEO and Director
2025-03-10Grant date for 2025 LTIP awards to Named Executive Officers
2025-01-29Announcement of strategic investment by KKR
2024-12-27Fiscal year end
2024-02-24Filing of Annual Report on Form 10-K for the year ended December 27, 2025
2023-12-30Fiscal year end
2022-12-31Fiscal year end
2021-12-25Fiscal year end
2020-12-27Fiscal year end

Recommendation

hold

The company is undergoing a significant leadership transition with the appointment of a new CEO and a reduction in board size. While the strategic partnership with KKR and the focus on financial performance are positive, the full impact of these changes on future financial results remains to be seen. Therefore, a 'hold' recommendation is appropriate pending further performance updates under the new leadership.

Keywords

Henry Schein, DEF 14A, Proxy Statement, Annual Meeting, Stockholders, Board of Directors, Executive Compensation, CEO Transition, Frederick M. Lowery, Stanley M. Bergman, KKR, Corporate Governance, BDO USA

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.